Primary orbital bone tumors constitute approximately 2% of all orbital masses.\[[@ref1]\] Amongst these, the chondromyxoid fibromas (CMFs) arising from orbital bones are even rarer. The reported overall incidence of CMFs is \<1% of all bone tumors, which commonly arise from the long bones of the limbs.\[[@ref2][@ref3]\] Secondary orbital involvement due to the extension of craniofacial CMFs has been infrequently reported in the literature.\[[@ref4][@ref5]\]

To the best of our knowledge, the primary orbital CMFs have been reported only thrice in the English literature (summarized in [Table 1](#T1){ref-type="table"}).\[[@ref6][@ref7][@ref8]\] In 2009, the first case of primary orbital CMF was reported by Heindel *et al*.\[[@ref6]\] We describe the clinical features, radiology, histopathology, and outcomes in the first report of primary orbital CMF from our country.

###### 

Primary orbital chondromyxoid fibromas: a review of literature

  Author/year      Age/gender   Duration     Chief complaints                                                                                                                                Evaluation                                                                                 Radiology                                                                                                                                                                          Management                                                                                                     Follow-up/outcome
  ---------------- ------------ ------------ ----------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------
  Heindl LM/2009   37y/F        3 years      Left supero- temporal orbital mass, proptosis                                                                                                   Visual acuity: 20/20 OU, non-axial proptosis=4 mm, choroidal folds +                       CT orbits: non-infiltrative mass with erosion of adjacent frontal bone                                                                                                             Transcutaneous extra-periosteal orbitotomy with complete mass excision                                         2 years/no recurrence (clinical)
  Ditta LC/2012    51y/F        Incidental   History of migraine; right orbital wall mass as an incidental finding on imaging                                                                Visual acuity: 20/20 OD & 20/30 OS; proptosis=3 mm; increased resistance to retropulsion   MRI: circumscribed lobulated intraosseous mass at the zygomatico-sphenoid junction                                                                                                 Surgical excision of extraosseous component                                                                    Recurrence at 5 months, re-surgery with the reconstruction of lateral orbit
  Mullen MG/2017   56y/M        Incidental   History of chronic sinusitis; Left orbital mass detected on imaging; Previous incisional biopsy- myxofibrosarcoma and advised an exenteration   Visual acuity: 20/20 OU, no proptosis                                                      CT: 3cm supero-temporal osteolytic lesion, before incisional biopsy MRI: multi-lobulated intensely enhancing expansile mass, 8 mm hypointense foci suggestive of the biopsy site   Combined neurosurgical and ophthalmologist approach for complete excision and histopathological confirmation   Follow up not mentioned
  Our Case         34y/F        5 months     Left non-axial proptosis of 5 months duration                                                                                                   Visual acuity: OD 20/20 & OS 20/60, choroidal folds +,                                     CT: superotemporal mass lesion with dense foci of calcification and effacement of orbital roof                                                                                     Transcutaneous anterior orbitotomy with mass excision, bony defect sealed with bone wax                        No recurrence at 8 months follow up

Case Report {#sec1-2}
===========

A 34-year-old lady had a 6-month history of painless, progressive, protrusion of the left eye. It was associated with diminution of vision for the last 3 months. On examination, the best-corrected visual acuity of the right and the left eye was 20/20 and 20/60, respectively. The left eyeball showed infero-medial displacement, 4 mm of proptosis, and limitation of elevation \[Fig. [1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\]. The fundus evaluation revealed choroidal folds at the posterior pole. A non-tender, firm-hard mass was palpable in supero-temporal quadrant of left orbit with raised retro-bulbar resistance.

![(a) Abaxial proptosis of the left eye with infero-medial displacement, (b) Limitation of left elevation, (c) CT scan (coronal sections) showing mildly enhancing, well-circumscribed mass in supero-temporal orbit with hyperdense foci and erosion of the adjacent frontal bone, (d) The bony window of CT scan (axial, superior sections) shows the same lesion with prominent hyperdense specs of calcification](IJO-67-2110-g001){#F1}

A computed tomography (CT) scan showed a well-defined mass in supero-temporal orbit, showing irregular hyperdense foci with surrounding frontal bone erosion \[Fig. [1c](#F1){ref-type="fig"} and [d](#F1){ref-type="fig"}\]. The mass was not separately visualized from the lacrimal gland. After obtaining informed consent, a transcutaneous anterior orbitotomy with mass excision was performed via a sub-brow Benedict\'s incision. Intraoperatively, a defect measuring 10mm × 12mm was identified in the supero-temporal orbital roof which was filled with bone wax.

The gross specimen measured 3 × 2.5 × 2.5 centimeters \[Fig. [2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\]. The histopathology showed the presence of a spindle/stellate type of cells in a chondroid matrix and hyaline cartilage with focal areas of ossification and few bony trabeculae \[Fig. 2c and d\]. The final diagnosis of chondromyxoid fibroma was established.

![(a) Intraoperative picture showing expression of large mass with the smooth orbital surface, (b) The orbital bone side of the same mass shows irregular, bosselated surface, (c) (H and E, 40×) The section shows a lobular configuration with myxoid background and interspersed cartilage, (d) Higher magnification (H and E, 200×) shows spindle/stellate cells with few cartilaginous areas undergoing ossification](IJO-67-2110-g002){#F2}

Her postoperative course was uneventful with complete resolution of proptosis, significant improvement in visual acuity and restoration of elevation, although the choroidal folds persisted for 4 months. At 12-months follow-up, no clinical features of local recurrence were noted \[Fig. [3a](#F3){ref-type="fig"} and [b](#F3){ref-type="fig"}\].

![(a) At 12 months follow-up, the left globe appears to be in normal position with a residual sub-brow scar, (b) The left elevation has also been restored to near normal](IJO-67-2110-g003){#F3}

Discussion {#sec1-3}
==========

Our case is a primary orbital CMF arising from the frontal bone with no extraorbital extension. CMFs are rare tumors presenting in 2^nd^ to 3^rd^ decade with a male preponderance.\[[@ref2][@ref3]\] The differential diagnosis for orbital bone tumors includes both benign (osteomas, fibrous dysplasia, chondroma, osteoblastoma and giant cell tumor) and malignant lesions (osteosarcoma, chondrosarcoma and Ewing\'s sarcoma).\[[@ref2][@ref3][@ref4][@ref5]\]

Any expansile and locally destructive lesion in the craniofacial skeleton must be evaluated and CMF should be thought of as a differential.\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] The CT scan features include an osteolytic lesion, well-defined lobulated margins with cortical erosion and septation (in long bones).\[[@ref9]\] Foci of calcification may be noted in 13% cases.\[[@ref2][@ref3]\] Calcification is more common in skull-base CMFs and the younger population.\[[@ref3][@ref9][@ref10]\] On MRI, the lesion is isointense (T1W) to muscle and homogenously hyperintense (T2W) with characteristic contrast enhancement.\[[@ref9][@ref10]\]

Histopathology provides the confirmative diagnosis and helps in planning further management. The histopathological differentials include both benign and malignant soft tissue, fibrous and fibro-histiocytic tumors like enchondromas, chondroblastoma, chondrosarcoma, chordoma, and myxofibrosarcoma \[[Table 2](#T2){ref-type="table"}\].\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] CMF is benign cartilage-forming tumors consisting of a collagenous to a myxoid matrix with the characteristic presence of stellate cells. On immunohistochemistry (IHC), they stain positive for smooth muscle antigen (SMA) and negative for keratin AE1/AE3.\[[@ref2][@ref3]\] Although Mullen *et al*. reported that a tailored IHC might not be very helpful for diagnosing CMF.\[[@ref8]\]

###### 

Differentiating clinical, radiological, histopathological and immunohistochemical features of similar orbital lesions

                           Chondromyxoid Fibroma                                                                                                                                 Chondroma                                                                                                                                          Osteoma                                                                                                                                                                                      Mesenchymal chondrosarcoma
  ------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Clinical features        Benign tumor 2^nd^ to 3^rd^ decade Male preponderance                                                                                                 Benign cartilaginous tumor No gender/age predilection Arise from trochlear/sphenoid bone                                                           Benign skeletal neoplasm 2^nd^ decade Males \> females Arise from paranasal sinuses                                                                                                          Recurrent tumor±distant metastasis 2^nd^ to 3^rd^ decade Female preponderance
  Radiology (CT scan)      well-defined mass, lobulated osteolytic lesion with bony cortical erosion & foci of calcification                                                     well-defined mass, minimally enhancing lesion with bony scalloping and erosion                                                                     well-circumscribed mass, dense cortical sclerosis around a radiolucent nidus                                                                                                                 well defined mass, heterogeneous enhancement, bony expansion without destruction with areas of mottled and fine calcification
  Histopathology           Gross- smooth to bosselated surface Microscopy- cartilage-forming benign tumour with collagenous to myxoid matrix and characteristic stellate cells   Grossly- glistening smooth surface Microscopy- multi-lobulated lesion with benign spindle cells resembling hyaline cartilage, no cellular atypia   Grossly- knob like protuberances over a glistening white-pink lesion Microscopy- central nidus of loose fibrovascular tissue surrounded by irregular trabeculae of bone and osteoid matrix   Grossly- lobulated surface, soft to firm consistency Microscopy- sheets/clusters of spindle- shaped mesenchymal cells; areas of cartilaginous tissue with atypia, focal calcification/cartilaginous changes
  Immunohisto- chemistry   S-100, SMA and SOX 9                                                                                                                                  S-100 and vimentin                                                                                                                                 S-100, EMA, NSE+ve                                                                                                                                                                           S-100 (cartilaginous area) Vimentin & CD99 (cellular component)

\*CT: Computed tomography; SMA: Smooth muscle antigen; EMA: Epithelial membrane antigen; NSE: Neuron specific enolase

Enchondromas show a lobulated architecture but the presence of hyaline cartilage in these tumors is a good differentiating feature. Both CMF and chondrosarcoma stain positive for S-100 and vimentin, but the absence of fibrous stroma in orbital chondrosarcomas differentiate it from CMFs.\[[@ref2][@ref3]\] Chordomas have infiltrative margins and are composed of nests/cords of large epithelial cells with eosinophilic or vacuolated cytoplasm, which may secondarily invade the orbital bone. On IHC, the chordomas express keratin and epithelial membrane antigen.\[[@ref1][@ref2][@ref3]\] In myxofibrosarcoma, a multi-nodular proliferation of stellate fibroblasts within a myxoid stroma with curvilinear blood vessels is noted. On IHC, the myxofibrosarcoma stains positive for vimentin.\[[@ref1][@ref2][@ref3]\]

Given the overlap of features, incisional biopsies or curettages may yield inadequate tissue leading to a possible erroneous diagnosis of malignant lesions like chondrosarcoma. This may change the further treatment course in the form of undue radiation and an unnecessary orbital exenteration. Moreover, an incomplete removal of a CMF can lead to a local recurrence. The reported recurrence rates range from 28% to 33% in the craniofacial sites.\[[@ref2][@ref6]\] Hence complete excision is recommended for both better histopathological identification and to reduce the risk of recurrence.

Conclusion {#sec1-4}
==========

In conclusion, primary orbital chondromyxoid fibroma is an extremely rare orbital bony tumor having a few typical radiological characters, and total excision with proper histopathology should be the aim for complete management.
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